VAERS reports by lot

Pfizer COVID-19 lot PAA165969: VAERS reports

65 VAERS reports list lot PAA165969 as a Pfizer COVID-19 vaccine, received between 2021-03-13 and 2024-02-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
22%
Marked serious
1
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular6322%
General / Systemic (non-local)5820%
Neurological5419%
Respiratory3412%
Gastrointestinal269%
Musculoskeletal145%
Dermatological (non-injection-site)124%
Thrombotic / Hematological93%
Injection-site / Local reaction93%
Psychiatric / Neuropsychiatric62%
Allergic / Anaphylactic31%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Indiana10
Florida8
California7
Texas5
Colorado3
Minnesota3
Iowa3
Missouri2
Michigan2
Idaho2
Louisiana2
Georgia2

Reports by month received

2021-036
2021-046
2021-055
2021-067
2021-075
2021-085
2021-0911
2021-108
2021-111
2021-122
2022-011
2022-021
2022-042
2022-051
2022-071
2022-081
2023-071
2024-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.